UniProt ID | FYN_MOUSE | |
---|---|---|
UniProt AC | P39688 | |
Protein Name | Tyrosine-protein kinase Fyn | |
Gene Name | Fyn | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 537 | |
Subcellular Localization | Cytoplasm. Nucleus. Cell membrane. Present and active in lipid rafts. Palmitoylation is crucial for proper trafficking (By similarity).. | |
Protein Description | Non-receptor tyrosine-protein kinase that plays a role in many biological processes including regulation of cell growth and survival, cell adhesion, integrin-mediated signaling, cytoskeletal remodeling, cell motility, immune response and axon guidance. Inactive FYN is phosphorylated on its C-terminal tail within the catalytic domain. Following activation by PKA, the protein subsequently associates with PTK2/FAK1, allowing PTK2/FAK1 phosphorylation, activation and targeting to focal adhesions. Involved in the regulation of cell adhesion and motility through phosphorylation of CTNNB1 (beta-catenin) and CTNND1 (delta-catenin). Regulates cytoskeletal remodeling by phosphorylating several proteins including the actin regulator WAS and the microtubule-associated proteins MAP2 and MAPT. Promotes cell survival by phosphorylating AGAP2/PIKE-A and preventing its apoptotic cleavage. Participates in signal transduction pathways that regulate the integrity of the glomerular slit diaphragm (an essential part of the glomerular filter of the kidney) by phosphorylating several slit diaphragm components including NPHS1, KIRREL1 and TRPC6. Plays a role in neural processes by phosphorylating DPYSL2, a multifunctional adapter protein within the central nervous system, ARHGAP32, a regulator for Rho family GTPases implicated in various neural functions, and SNCA, a small pre-synaptic protein. Participates in the downstream signaling pathways that lead to T-cell differentiation and proliferation following T-cell receptor (TCR) stimulation. Also participates in negative feedback regulation of TCR signaling through phosphorylation of PAG1, thereby promoting interaction between PAG1 and CSK and recruitment of CSK to lipid rafts. CSK maintains LCK and FYN in an inactive form. Promotes CD28-induced phosphorylation of VAV1 (By similarity).. | |
Protein Sequence | MGCVQCKDKEAAKLTEERDGSLNQSSGYRYGTDPTPQHYPSFGVTSIPNYNNFHAAGGQGLTVFGGVNSSSHTGTLRTRGGTGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCRLVVPCHKGMPRLTDLSVKTKDVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQGFLEDYFTATEPQYQPGENL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Myristoylation | ------MGCVQCKDK ------CCCEECCCH | 21.94 | 8655574 | |
2 | N-myristoyl glycine | ------MGCVQCKDK ------CCCEECCCH | 21.94 | - | |
3 | S-palmitoylation | -----MGCVQCKDKE -----CCCEECCCHH | 1.52 | 7518463 | |
6 | S-palmitoylation | --MGCVQCKDKEAAK --CCCEECCCHHHHH | 2.84 | 7980442 | |
13 | Ubiquitination | CKDKEAAKLTEERDG CCCHHHHHCCHHCCC | 64.09 | 27667366 | |
15 | Phosphorylation | DKEAAKLTEERDGSL CHHHHHCCHHCCCCC | 34.78 | 28833060 | |
21 | Phosphorylation | LTEERDGSLNQSSGY CCHHCCCCCCCCCCC | 28.56 | 25521595 | |
21 (in isoform 2) | Phosphorylation | - | 28.56 | 19144319 | |
25 | Phosphorylation | RDGSLNQSSGYRYGT CCCCCCCCCCCCCCC | 25.34 | 26824392 | |
26 | Phosphorylation | DGSLNQSSGYRYGTD CCCCCCCCCCCCCCC | 30.04 | 26824392 | |
28 | Phosphorylation | SLNQSSGYRYGTDPT CCCCCCCCCCCCCCC | 11.56 | 18515860 | |
50 | Phosphorylation | GVTSIPNYNNFHAAG CCCCCCCCCCCCCCC | 13.21 | 29514104 | |
91 | Phosphorylation | VTLFVALYDYEARTE EEEEEEEEECCCCCC | 13.52 | - | |
150 | Phosphorylation | SIQAEEWYFGKLGRK CCCCHHHHCCCCCCH | 13.01 | 25338131 | |
165 | Phosphorylation | DAERQLLSFGNPRGT HHHHHHHHCCCCCCE | 39.43 | 28418008 | |
182 | Ubiquitination | IRESETTKGAYSLSI EEECCCCCCEEEEEE | 44.95 | 27667366 | |
185 | Phosphorylation | SETTKGAYSLSIRDW CCCCCCEEEEEEEEH | 20.86 | 25521595 | |
186 | Phosphorylation | ETTKGAYSLSIRDWD CCCCCEEEEEEEEHH | 18.33 | 23737553 | |
188 | Phosphorylation | TKGAYSLSIRDWDDM CCCEEEEEEEEHHHC | 15.05 | 25367039 | |
213 | Phosphorylation | RKLDNGGYYITTRAQ EECCCCCEEEEEHHH | 7.97 | 25521595 | |
214 | Phosphorylation | KLDNGGYYITTRAQF ECCCCCEEEEEHHHH | 8.61 | 21082442 | |
216 | Phosphorylation | DNGGYYITTRAQFET CCCCEEEEEHHHHHH | 8.29 | 19060867 | |
217 | Phosphorylation | NGGYYITTRAQFETL CCCEEEEEHHHHHHH | 17.91 | 20415495 | |
254 | Phosphorylation | HKGMPRLTDLSVKTK CCCCCCCCCCCEECC | 35.85 | 19131326 | |
257 | Phosphorylation | MPRLTDLSVKTKDVW CCCCCCCCEECCCHH | 25.11 | 22817900 | |
267 (in isoform 2) | Phosphorylation | - | 23.59 | 27600695 | |
320 | Methylation | EEAQIMKKLKHDKLV HHHHHHHHCCCCCEE | 45.44 | - | |
322 | Methylation | AQIMKKLKHDKLVQL HHHHHHCCCCCEEEE | 59.65 | - | |
339 | Phosphorylation | VVSEEPIYIVTEYMS EECCCCEEEEEEECC | 10.47 | - | |
393 | Phosphorylation | YIHRDLRSANILVGN HHCCCHHHCCEEECC | 32.72 | 22817900 | |
417 (in isoform 2) | Phosphorylation | - | 46.39 | 19144319 | |
420 | Phosphorylation | RLIEDNEYTARQGAK HHHCCCCCCCCCCCC | 16.38 | 18515860 | |
421 | Phosphorylation | LIEDNEYTARQGAKF HHCCCCCCCCCCCCC | 14.80 | 27566939 | |
440 | Phosphorylation | TAPEAALYGRFTIKS CCCCHHHHCCEEECC | 11.09 | 20116462 | |
461 | Phosphorylation | ILLTELVTKGRVPYP HHHHHHHHCCCCCCC | 40.17 | 22871156 | |
525 | Phosphorylation | GFLEDYFTATEPQYQ HHHHHHHCCCCCCCC | 26.83 | 25293948 | |
527 | Phosphorylation | LEDYFTATEPQYQPG HHHHHCCCCCCCCCC | 45.18 | 25293948 | |
531 | Phosphorylation | FTATEPQYQPGENL- HCCCCCCCCCCCCC- | 27.65 | 18809727 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FYN_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ENOA_MOUSE | Eno1 | physical | 18854310 | |
CBL_MOUSE | Cbl | physical | 8551236 | |
KHDR1_MOUSE | Khdrbs1 | physical | 10844001 | |
CBL_MOUSE | Cbl | physical | 9890970 | |
P85A_MOUSE | Pik3r1 | physical | 9115297 | |
DIAP1_MOUSE | Diap1 | physical | 18194650 | |
ZN106_MOUSE | Zfp106 | physical | 9507006 | |
CBL_MOUSE | Cbl | physical | 8635998 | |
CBL_MOUSE | Cbl | physical | 9210408 | |
NCK1_MOUSE | Nck1 | physical | 16966330 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Myristoylation | |
Reference | PubMed |
"Multiple features of the p59fyn src homology 4 domain define a motiffor immune-receptor tyrosine-based activation motif (ITAM) binding andfor plasma membrane localization."; Gauen L.K.T., Linder M.E., Shaw A.S.; J. Cell Biol. 133:1007-1015(1996). Cited for: MYRISTOYLATION AT GLY-2. | |
Palmitoylation | |
Reference | PubMed |
"Palmitoylation of p59fyn is reversible and sufficient for plasmamembrane association."; Wolven A., Okamura H., Rosenblatt Y., Resh M.D.; Mol. Biol. Cell 8:1159-1173(1997). Cited for: PALMITOYLATION AT CYS-3, AND MUTAGENESIS OF CYS-3. | |
"Palmitoylation of multiple Src-family kinases at a homologous N-terminal motif."; Koegl M., Zlatkine P., Ley S.C., Courtneidge S.A., Magee A.I.; Biochem. J. 303:749-753(1994). Cited for: PALMITOYLATION AT CYS-3 AND CYS-6, AND MUTAGENESIS OF GLY-2; CYS-3 ANDCYS-6. | |
"Palmitylation of an amino-terminal cysteine motif of protein tyrosinekinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins."; Shenoy-Scaria A.M., Timson L.K., Kwong J., Shaw A.S., Lublin D.M.; Mol. Cell. Biol. 13:6385-6392(1993). Cited for: PALMITOYLATION AT CYS-3 AND CYS-6, AND MUTAGENESIS OF CYS-3 AND CYS-6. | |
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-254 AND SER-257, ANDMASS SPECTROMETRY. | |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-420, AND MASSSPECTROMETRY. | |
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185 AND TYR-531, ANDMASS SPECTROMETRY. | |
"Differential effects of expression of the CD45 tyrosine proteinphosphatase on the tyrosine phosphorylation of the lck, fyn, and c-srctyrosine protein kinases."; Hurley T.R., Hyman R., Sefton B.M.; Mol. Cell. Biol. 13:1651-1656(1993). Cited for: PHOSPHORYLATION AT TYR-531, AUTOPHOSPHORYLATION AT TYR-420, AND ENZYMEREGULATION. |